Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Characterization of EIAV env Quasispecies during Long-Term Passage In Vitro: Gradual Loss of Pathogenicity.

Liu C, Wang XF, Wang Y, Chen J, Zhong Z, Lin Y, Wang X.

Viruses. 2019 Apr 24;11(4). pii: E380. doi: 10.3390/v11040380.

2.

Development of antigen capture ELISA for the quantification of EIAV p26 protein.

Hu Z, Chang H, Ge M, Lin Y, Wang X, Guo W, Wang X.

Appl Microbiol Biotechnol. 2014 Nov;98(21):9073-81. doi: 10.1007/s00253-014-6078-8. Epub 2014 Sep 26.

PMID:
25256618
3.

Comprehensive analysis of the overall codon usage patterns in equine infectious anemia virus.

Yin X, Lin Y, Cai W, Wei P, Wang X.

Virol J. 2013 Dec 20;10:356. doi: 10.1186/1743-422X-10-356.

4.

A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccine.

Meng Q, Lin Y, Ma J, Ma Y, Zhao L, Li S, Yang K, Zhou J, Shen R, Zhang X, Shao Y.

Viral Immunol. 2012 Dec;25(6):477-84. doi: 10.1089/vim.2012.0014. Epub 2012 Nov 21.

5.

A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.

Meng Q, Lin Y, Ma J, Ma Y, Zhao L, Li S, Liang H, Zhou J, Shen R, Zhang X, Shao Y.

Arch Virol. 2011 Aug;156(8):1455-62. doi: 10.1007/s00705-011-0992-1. Epub 2011 Apr 17.

PMID:
21499906
6.

Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.

Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Wang F, Shen R, Zhou J.

Virus Genes. 2011 Apr;42(2):220-8. doi: 10.1007/s11262-010-0563-7. Epub 2011 Jan 8.

PMID:
21369830
7.

Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.

Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Wang F, Shen R, Kong X, Zhou J.

Arch Virol. 2011 Feb;156(2):353-7. doi: 10.1007/s00705-010-0877-8. Epub 2010 Dec 7.

PMID:
21136127
8.

Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.

Qi X, Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Shen R, Wang F, Kong X, Su Z, Zhou J.

Virus Genes. 2010 Aug;41(1):86-98. doi: 10.1007/s11262-010-0491-6. Epub 2010 Jun 5.

PMID:
20526660
9.

In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.

Ma J, Jiang C, Lin Y, Wang X, Zhao L, Xiang W, Shao Y, Shen R, Kong X, Zhou J.

Arch Virol. 2009;154(5):867-73. doi: 10.1007/s00705-009-0378-9. Epub 2009 Apr 12.

PMID:
19363668
10.

[A flow cytometric assay for the expression of interferon gamma in T lymphocytes and its application in the study of EIAV-induced immune response].

Lin Y, Deng X, Shen N, Zhao L, Meng Q, Max J, Wang J, Shao Y, Zhou J.

Wei Sheng Wu Xue Bao. 2008 Jun;48(6):800-5. Chinese.

PMID:
18720846

Supplemental Content

Loading ...
Support Center